tirzepatide semaglutide conversion What is the recommended dose from (glucagon-like peptide-1 (GLP-1) receptor agonist) 2mg per week to (dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist)? Tirzepatide and Semaglutide key differences,
Description
Your GP can advise on the most appropriate option, with long-term PPI use reviewed after 4-8 weeks in line with NICE guidance
Crohn's disease is more common in young people between 15-30
This does not mean the medication has stopped working, only that your body has reached a new equilibrium point
It can also act as a prebiotic, feeding the good bacteria in your gut
Get provider-reviewed GLP-1 therapy Side effects are manageable with the right support
